IGMS - IGM Biosciences announces refocusing of Sanofi collaboration
2024-04-17 08:48:28 ET
More on IGM Biosciences
- IGM Biosciences: Imvotamab Data 2nd Half Of 2024 With Other Inflection Points
- IGM Biosciences GAAP EPS of -$1.01 beats by $0.08, revenue of $0.7M misses by $0.07M
- RBC Capital upgrades IGM Biosciences to outperform
- Seeking Alpha’s Quant Rating on IGM Biosciences
- Historical earnings data for IGM Biosciences